SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001395064-20-000024
Filing Date
2020-01-27
Accepted
2020-01-27 06:03:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A sc13da_012720.htm SC 13D/A 45585
  Complete submission text file 0001395064-20-000024.txt   47115
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089
Business Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089 650-325-5156
Phathom Pharmaceuticals, Inc. (Subject) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91182 | Film No.: 20547033
SIC: 2834 Pharmaceutical Preparations